ASP Isotopes (ASPI) Net Equity Issued and Repurchased (2022 - 2025)

ASP Isotopes' Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $210.3 million for Q4 2025.

• On a quarterly basis, Net Equity Issued and Repurchased rose 1031.21% year-over-year to $210.3 million in Q4 2025; TTM through Dec 2025 was $316.7 million, a 496.51% increase from a year earlier, with the FY2025 full-year figure at $320.3 million, up 503.31% from the prior year.
• Net Equity Issued and Repurchased rose to $210.3 million in Q4 2025 per ASPI's latest filing, from $41.0 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $210.3 million in Q4 2025 and bottomed at $744350.0 in Q2 2022.
• The 4-year median for Net Equity Issued and Repurchased is $9.1 million (2023), against an average of $33.9 million.
• Biggest YoY gain for Net Equity Issued and Repurchased was 1031.21% in 2025; the steepest drop was 41.56% in 2025.
• Year by year, Net Equity Issued and Repurchased stood at $5.0 million in 2022, then soared by 82.58% to $9.1 million in 2023, then surged by 103.64% to $18.6 million in 2024, then jumped by 1031.21% to $210.3 million in 2025.
• Per Business Quant, the three latest ASPI Net Equity Issued and Repurchased figures stand at $210.3 million (Q4 2025), $41.0 million (Q3 2025), and $46.8 million (Q2 2025).